BE872990A - Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique - Google Patents

Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique

Info

Publication number
BE872990A
BE872990A BE1009211A BE1009211A BE872990A BE 872990 A BE872990 A BE 872990A BE 1009211 A BE1009211 A BE 1009211A BE 1009211 A BE1009211 A BE 1009211A BE 872990 A BE872990 A BE 872990A
Authority
BE
Belgium
Prior art keywords
pyrindins
octahydro
trans
aryl
therapeutic use
Prior art date
Application number
BE1009211A
Other languages
English (en)
Inventor
D M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE872990A publication Critical patent/BE872990A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BE1009211A 1977-12-27 1978-12-22 Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique BE872990A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86489977A 1977-12-27 1977-12-27

Publications (1)

Publication Number Publication Date
BE872990A true BE872990A (fr) 1979-06-22

Family

ID=25344312

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1009211A BE872990A (fr) 1977-12-27 1978-12-22 Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique

Country Status (24)

Country Link
EP (1) EP0002937A1 (fr)
JP (1) JPS5498770A (fr)
AR (1) AR221352A1 (fr)
AU (1) AU4286678A (fr)
BE (1) BE872990A (fr)
BG (1) BG30927A3 (fr)
CA (1) CA1105026A (fr)
CS (1) CS203940B2 (fr)
DD (1) DD141156A5 (fr)
DK (1) DK577078A (fr)
ES (1) ES476385A1 (fr)
FI (1) FI783992A (fr)
FR (1) FR2413370A1 (fr)
GB (1) GB2010806A (fr)
GR (1) GR70349B (fr)
IL (1) IL56268A0 (fr)
IT (1) IT1101682B (fr)
LU (1) LU80719A1 (fr)
NZ (1) NZ189230A (fr)
PL (1) PL117572B1 (fr)
PT (1) PT68934A (fr)
RO (1) RO75805A (fr)
SU (1) SU841586A3 (fr)
ZA (1) ZA787156B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537963A (en) * 1981-12-28 1985-08-27 E. I. Du Pont De Nemours And Company Intermediates for octahydrobenzofuro[3,2-E]isoquinolines
US4415736A (en) * 1981-12-28 1983-11-15 E. I. Du Pont De Nemours & Co. Certain tetrahydropyridine intermediates
US4579952A (en) * 1981-12-28 1986-04-01 E. I. Du Pont De Nemours And Company Intermediates for octahydrobenzofuro[3,2-e]isoquinolines
FR2617481B1 (fr) * 1987-07-03 1989-11-10 Roussel Uclaf Nouveaux derives de la tetrahydropyridine, leur procede de preparation et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
HUE028983T2 (en) 2010-05-06 2017-01-30 Vertex Pharma Heterocyclic chromene-spirocyclic piperidine amides as ion channel modulators
EP3056495A1 (fr) 2011-02-02 2016-08-17 Vertex Pharmaceuticals Inc. Amides pipéridines pyrrolopyrazine-spirocycliques en tant que modulateurs de canaux ioniques
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
WO2012125613A1 (fr) 2011-03-14 2012-09-20 Vertex Pharmaceuticals Incorporated Amides de pipéridine spirocycliques morpholines utilisés en tant que modulateurs de canaux ioniques
WO2015006280A1 (fr) * 2013-07-10 2015-01-15 Vertex Pharmaceuticals Incorporated Amides de pipéridine fusionnés utiles en tant que modulateurs de canaux ioniques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA734895B (en) * 1972-07-20 1974-06-26 Du Pont Analgesigs and/or narcotic antagonists
CA1024149A (fr) * 1972-07-20 1978-01-10 E.I. Du Pont De Nemours And Company 4.alpha.-ARYL-TRANS-DECAHYDROISOQUINOLINES
PT67194B (en) * 1976-11-02 1979-03-23 Lilly Co Eli Process for preparing 4a-aryl-octahydro-1h-2-pyrindines

Also Published As

Publication number Publication date
DD141156A5 (de) 1980-04-16
AR221352A1 (es) 1981-01-30
LU80719A1 (fr) 1979-04-13
AU4286678A (en) 1979-07-05
CS203940B2 (en) 1981-03-31
ZA787156B (en) 1980-08-27
PT68934A (en) 1979-01-01
BG30927A3 (en) 1981-09-15
EP0002937A1 (fr) 1979-07-11
NZ189230A (en) 1981-05-15
DK577078A (da) 1979-06-28
PL117572B1 (en) 1981-08-31
CA1105026A (fr) 1981-07-14
JPS5498770A (en) 1979-08-03
FR2413370A1 (fr) 1979-07-27
IT1101682B (it) 1985-10-07
IT7831268A0 (it) 1978-12-22
ES476385A1 (es) 1979-11-16
GR70349B (fr) 1982-09-23
RO75805A (fr) 1981-02-28
IL56268A0 (en) 1979-03-12
GB2010806A (en) 1979-07-04
SU841586A3 (ru) 1981-06-23
FI783992A (fi) 1979-06-28
PL211919A1 (pl) 1979-09-10

Similar Documents

Publication Publication Date Title
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE872489A (fr) Derives heterosidiques de pleuromutiline et leur utilisation therapeutique
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE872886A (fr) Steroides, leur preparation et leur utilisation therapeutique
BE870819A (fr) Nouveaux tetrapeptides et leur utilisation therapeutique
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE863702A (fr) Tetrazolylcarbamoylquinoleines et leur preparation
BE869382A (fr) Agents tensio-actifs et leur utilisation
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE869352A (fr) Nouvelles nitrosourees et leur application
BE882010A (fr) Tetrahydrobenzothiazolylimidazolidinones et leur utilisation
BE868953A (fr) Peptides, leur preparation et leur utilisation
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
BE866544A (fr) Nouvelles 3-amino-2-or-propoxy-naphtyridines et leur utilisation
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
LU81454A1 (fr) R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylamines et leur utilisation therapeutique
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
BE869959A (fr) 2-1-benzisothiazoles, leur preparation et leur utilisation therapeutique
BE863142A (fr) Tetrazoles et leur preparation
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique